Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth

Investing.com -- Mettler-Toledo faces a growing mismatch between its premium valuation and a more modest growth outlook as competition intensifies across its weighing and laboratory businesses, brokerage Redburn said on Wednesday, initiating coverage of the precision-instrument maker with a Sell rating.

Redburn set a $1,200 price target, implying about 15% downside from the company's $1,405 share price. The brokerage said the stock was trading at about 27 times its 2027 expected earnings, a premium to global life-science tools peers that it believes leaves limited room for further multiple expansion.

The bearish view does not stem from concerns about the company's returns or market position. Redburn said Mettler-Toledo has best-in-class returns, with return on invested capital of about 28%, as well as a strong brand, a large installed base and an expanding services business. Instead, the brokerage argued that mature end markets, increasing commoditisation and persistent pressure in China could constrain future growth and pricing power.

Redburn expects revenue to rise to $4.25 billion in 2026 from $4.03 billion in 2025, with adjusted diluted earnings per share forecast at $47.29, up from $42.73. For 2027, it projects revenue of $4.44 billion and adjusted EPS of $51.40. The brokerage expects adjusted EBITA margins to improve gradually, reaching 31.4% by 2029, but forecasts remain below consensus on adjusted EPS for 2027-29.

Redburn's central concern is that Mettler-Toledo's premium pricing and valuation leave little room for disappointment. Its core laboratory and weighing markets are growing only around 3%-4% annually, while competitors are improving product quality and narrowing technological differences. China, which accounts for 16% of group revenue compared with a 10% peer average, adds another source of pressure.

The brokerage said laboratory operations, which account for 56% of revenue, remain supported by strong positions in precision balances, pipettes and analytical instruments. But it sees increasing pressure on pricing as alternatives improve, particularly at the lower end of the weighing market where Chinese manufacturers are becoming more competitive.

Redburn also flagged industrial weighing as particularly exposed to competition because customers are generally more price-sensitive and less willing to pay a premium for incremental improvements in accuracy. It expects the Industrial segment, which represents 39% of revenue, to deliver a 3.9% revenue compound annual growth rate from 2026 to 2029.

The brokerage acknowledged that some parts of the portfolio offer stronger growth prospects. Process Analytical Technology, or PAT, is estimated to be growing at about 13%, well ahead of the roughly 3%-4% growth expected for laboratory balances and pipettes. Redburn views PAT as one of Mettler-Toledo's most defensible businesses because of its integration into regulated biopharmaceutical manufacturing processes and the resulting high switching costs.

Services provide another source of resilience. Service revenue represented about 25% of group revenue, up from 23% in 2023, supported by calibration, compliance, certification and maintenance contracts tied to the company's large installed base.

Still, Redburn forecasts group revenue growth of only 4.8% over the medium term and expects its cautious estimates to remain 1%-3% below consensus on an adjusted EPS basis from 2027 through 2029. Buybacks are expected to contribute roughly 300 basis points to EPS growth, while productivity initiatives and operating leverage should support margin expansion

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
• TSX movers: VersaBank jumps 10% as corporate catalysts lift top gainers